Autolus Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.

About AUTL

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.

CEO

Christian Martin Itin

CEOChristian Martin Itin

Employees

752

Employees752

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2018

Founded2018

Employees

752

Employees752

AUTL Key Statistics

Market cap

680.81M

Market cap680.81M

Price-Earnings ratio

-1.91

Price-Earnings ratio-1.91

Dividend yield

—

Dividend yield—

Average volume

3.17M

Average volume3.17M

High today

$2.37

High today$2.37

Low today

$2.00

Low today$2.00

Open price

$2.04

Open price$2.04

Volume

3.33M

Volume3.33M

52 Week high

$2.52

52 Week high$2.52

52 Week low

$1.18

52 Week low$1.18

AUTL News

TipRanks 4h

Autolus Lifts 2026 Guidance as AUCATZYL Sales Surge

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 5h

Autolus Therapeutics reports Q2 EPS (15c), consensus (19c)

Reports Q2 revenue $45.69M, consensus $40.15M. “In the second quarter we achieved substantial sales growth in the ongoing AUCATZYL launch, driven by physician e...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell